PRECIGEN INC's ticker is PGEN and the CUSIP is 74017N105. A total of 171 filers reported holding PRECIGEN INC in Q4 2021. The put-call ratio across all filers is 1.31 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $44,764 | +24.3% | 31,524 | +0.7% | 0.00% | – |
| Q2 2023 | $36,010 | -74.1% | 31,313 | -76.1% | 0.00% | – |
| Q1 2023 | $138,936 | +115.0% | 131,072 | +208.3% | 0.00% | – |
| Q4 2022 | $64,626 | -34.1% | 42,517 | -8.2% | 0.00% | – |
| Q3 2022 | $98,000 | +71.9% | 46,332 | +9.3% | 0.00% | – |
| Q2 2022 | $57,000 | -38.7% | 42,391 | -4.9% | 0.00% | – |
| Q1 2022 | $93,000 | -42.6% | 44,573 | +2.1% | 0.00% | – |
| Q4 2021 | $162,000 | -35.5% | 43,652 | -12.9% | 0.00% | – |
| Q3 2021 | $251,000 | -96.8% | 50,098 | -95.9% | 0.00% | -100.0% |
| Q2 2021 | $7,880,000 | +20.3% | 1,208,714 | +27.2% | 0.00% | 0.0% |
| Q1 2021 | $6,548,000 | -48.1% | 950,434 | -23.2% | 0.00% | -50.0% |
| Q4 2020 | $12,615,000 | +7150.0% | 1,236,788 | +2389.3% | 0.00% | – |
| Q3 2020 | $174,000 | -95.9% | 49,684 | -94.1% | 0.00% | -100.0% |
| Q2 2020 | $4,209,000 | +2482.2% | 843,453 | +1652.8% | 0.00% | – |
| Q1 2020 | $163,000 | – | 48,121 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Patient Capital Management, LLC | 13,753,176 | $19,529,510 | 1.15% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 2,078,220 | $2,951,072 | 0.60% |
| EMFO, LLC | 425,000 | $603,500 | 0.57% |
| Opaleye Management Inc. | 928,500 | $1,318,470 | 0.43% |
| First Washington CORP | 646,575 | $918,137 | 0.37% |
| Fore Capital, LLC | 426,791 | $606,043 | 0.26% |
| SANDERS MORRIS HARRIS LLC | 410,000 | $582,200 | 0.12% |
| MSD Partners, L.P. | 960,000 | $1,363,200 | 0.11% |
| Virtus ETF Advisers LLC | 79,754 | $113,251 | 0.07% |
| CHIRON CAPITAL MANAGEMENT, LLC | 55,850 | $79,307 | 0.07% |